APA (7th ed.) Citation

RJ, M., JF, M., XJ, M., M, S., DJ, G., O, V., . . . A, R. (2022). Molecular characterization of renal cell carcinoma tumors from a phase III anti-angiogenic adjuvant therapy trial. Nature communications, 13(1), 5959. https://doi.org/10.1038/s41467-022-33555-8

Chicago Style (17th ed.) Citation

RJ, Motzer, et al. "Molecular Characterization of Renal Cell Carcinoma Tumors from a Phase III Anti-angiogenic Adjuvant Therapy Trial." Nature Communications 13, no. 1 (2022): 5959. https://doi.org/10.1038/s41467-022-33555-8.

MLA (9th ed.) Citation

RJ, Motzer, et al. "Molecular Characterization of Renal Cell Carcinoma Tumors from a Phase III Anti-angiogenic Adjuvant Therapy Trial." Nature Communications, vol. 13, no. 1, 2022, p. 5959, https://doi.org/10.1038/s41467-022-33555-8.